Searching journal content for breast cancer (as phrase) in full text.

Displaying results 1-10 of 1174
For checked items
  1. Thematic Review:
    • Lucas Leite Cunha,
    • Marjory Alana Marcello,
    • Vinicius Rocha-Santos,
    • and Laura Sterian Ward
    Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Endocr Relat Cancer 24 (12) T261-T281, doi:10.1530/ERC-17-0222 first published on 11 September 2017
    .../kg (durvalumab) + 200 or 300 mg (olaparib) 2/day; 1500 mg (durvalumab) + 300 mg (olaparib) 2/day Ovarian cancer and triple-negative breast cancer 10 patients with ovarian cancer + 2 patients with triple-negative breast cancer I/II 11.1% (6months) NR NR 55.5% (4months) NR NR NR 25% Lee etal. (2016 ~~~
  2. Thematic Review:
    • Melissa Gamat and
    • Douglas G McNeel
    Androgen deprivation and immunotherapy for the treatment of prostate cancer Endocr Relat Cancer 24 (12) T297-T310, doi:10.1530/ERC-17-0145 first published on 16 August 2017
    ...breast cancer and improves survival in a spontaneous prostate cancer model. Oncotarget 6 28194–28210. (doi:10.18632/ oncotarget.4442) Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, et al. 2014 Ipilimumab versus placebo after radiother ~~~
  3. Thematic Review:
    • Priscilla Cukier,
    • Fernando C Santini,
    • Mariana Scaranti,
    • and Ana O Hoff
    Endocrine side effects of cancer immunotherapy Endocr Relat Cancer 24 (12) T331-T347, doi:10.1530/ERC-17-0358 first published on 12 October 2017
    ...breast cancer ~~~
  4. Thematic Review:
    • Robert C Mould,
    • Jacob P van Vloten,
    • Amanda W K AuYeung,
    • Khalil Karimi,
    • and Byram W Bridle
    Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission Endocr Relat Cancer 24 (12) T311-T329, doi:10.1530/ERC-17-0316 first published on 14 September 2017
    .... 2003, Sato et al. 2005), colorectal (Galon et al. 2006, Teng et al. 2015) and breast cancers (Wang et al. 2016). In human papillary thyroid cancers, lymphocyte density is also associated with better overall survival and lower recurrence of tumors (Matsubayashi et al. 1995, Kuo et al. 2017 ~~~
  5. Review:
    • Vincenzo Marotta,
    • Maria Chiara Zatelli,
    • Concetta Sciammarella,
    • Maria Rosaria Ambrosio,
    • Marta Bondanelli,
    • Annamaria A L Colao,
    • and Antongiulio Faggiano
    Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer ERC-17-0269, doi:10.1530/ERC-17-0269 first published on 24 October 2017
    ...neuroendocrine differentiation has not been reported, such as primary hepatocellular 315 cancer (Spadaro et al. 2005) and breast cancer (Giovanella et al. 2001). To date, the capability of 316 circulating CgA in discriminating NEN from other malignancies has been evaluated by many 317 studies, which reported ~~~
  6. Research:
    • B Wan,
    • L Dai,
    • L Wang,
    • Y Zhang,
    • H Huang,
    • G Qian,
    • and T Yu
    Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells Endocr Relat Cancer ERC-17-0261, doi:10.1530/ERC-17-0261 first published on 24 October 2017
    ...remained unclear. Knockdown of BRCA2 enhanced 351 cell death induced by AZ2281 (a PARP inhibitor) in breast cancer cells, where autophagy 352 was involved in cell death via eliminating mitochondria (Arun et al. 2015). DNA damages 353 induced autophagy via the ATM- or PARP1-dependent pathway (Eliopoulos et ~~~
  7. Research:
    • Amruta Ashtekar,
    • Danielle Huk,
    • Alexa Magner,
    • Krista La Perle,
    • Xiaoli Zhang,
    • José I Piruat,
    • José López-Barneo,
    • Sissy M Jhiang,
    • and Lawrence S Kirschner
    Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype Endocr Relat Cancer 24 (11) 579-591, doi:10.1530/ERC-17-0229 first published on 19 September 2017
    ...of rare high penetrance genetic syndromes or from more prevalent low-penetrance susceptibility genes (Nagy et al. 2004, Tomsic et al. 2015). Cowden syndrome (CS) is an autosomal dominant disorder that is characterized by high risk of breast cancer, thyroid neoplasms, uterine tumors, gastrointestinal ~~~
  8. Research:
    • Zhu Wang,
    • Dinglan Wu,
    • Chi-Fai Ng,
    • Jeremy Yuen-Chun Teoh,
    • Shan Yu,
    • Yuliang Wang,
    • and Franky Leung Chan
    Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer Endocr Relat Cancer ERC-17-0280, doi:10.1530/ERC-17-0280 first published on 17 October 2017
    ...and hepatoma cells (Moya, et al. 2010)], embryonic stem cells (Xie, et al. 2009) and also a 113 few cancer types [including lung cancer (Jeong, et al. 2010); colon cancer (Modica, et al. 114 2009); breast cancer stromal cells (Knower, et al. 2013)]. The expression profile datasets of 115 NRs as disclosed ~~~
  9. Research:
    • Justin Brown,
    • Michael Rickels,
    • Andrea Troxel,
    • Babette Zemel,
    • Nevena Damjanov,
    • Bonnie Ky,
    • Andrew Rhim,
    • Anil Rustgi,
    • Kerry S Courneya,
    • and Kathryn Schmitz
    Dose-response effects of exercise on insulin among colon cancer survivors Endocr Relat Cancer ERC-17-0377, doi:10.1530/ERC-17-0377 first published on 10 October 2017
    ...survivors have significantly higher fasting insulin 231 concentrations than healthy persons (Jiang et al. 2014). Our findings are similar to studies in 232 breast cancer survivors that exise reduces fasting insulin concentrations (Irwin, et al. 2009; 233 Ligibel, et al. 2008). 234 In prior cross ~~~
  10. Research:
    • Keren Cohen,
    • Uri Abadi,
    • Aleck Hercbergs,
    • Paul J Davis,
    • Martin Ellis,
    • and Osnat Ashur-Fabian
    The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative Endocr Relat Cancer ERC-17-0246, doi:10.1530/ERC-17-0246 first published on 10 October 2017
    ..., Luidens MK, Mousa SA, Hbergs 533 AH & Davis PJ 2009 Modification of survival pathway gene expression in human breast cancer 534 cells by tetraiodothyroacetic acid (tetrac). Cell Cycle 8 3554-3562. 535 Hellevik A, Asvold B, Bjro T, Romundstad P, Nilsen T & Vatten L 2009 Thyroid function and 536 cancer ~~~
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most